Eagle Health Investments LP
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1842545
Greenwich, CT
Position in PTGX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$30,439,310
+$11,538,772 QoQ
Shares Held
248,322
+38.5% QoQ
Ownership
0.384%
of shares outstanding
% of Portfolio
5.05%
of 13F equity value
Holder Rank
#42
of 341 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eagle Health Investments LP holds $387,533,407 across 16 Biotechnology names. PTGX ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
76,417 | $70,897,400 | |
| 2 | INSM |
INSMED Inc
|
384,130 | $40,955,940 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
624,676 | $35,743,960 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
555,272 | $30,539,960 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
This page
|
248,322 | $30,439,310 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
884,121 | $29,520,800 | |
| 7 | ASND |
Ascendis Pharma A/S
|
106,158 | $28,314,461 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
120,346 | $22,538,398 |
All Filings in PTGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,439,310 | 248,322 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $18,900,538 | 179,322 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,004,582 | 57,300 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||